5KP-22461-16741
2 vaccinations
3 coded responses
20 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 379 / TN
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Registered in v-safe
-
2021-01-21
Dose 1 — Pfizer-BioNTech
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
-
2021-02-04
Survey response — day 14, dose 1MedDRA: Headache — Feeling: GoodFree text: Headache for 2 daysMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-11
-
2021-02-12
Dose 2 — Pfizer-BioNTech
-
2021-02-18
Survey response — days 1–6 daily, dose 2MedDRA: Ear discomfort, Rhinorrhoea — Feeling: Fair · Site: PainFree text: Runny nose, ear pressure popping sensationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-19
- 2021-03-26
- 2021-05-14
- 2021-08-13
-
2022-02-12
Survey response — 12 months, dose 2MedDRA: Asthenia, Cough, Eye pruritus, Fatigue, Lacrimation increased, Ophthalmic migraine, Pruritus, Rhinorrhoea, SARS-CoV-2 test positive, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Tested Covid positive Cough Fatigue Optical migraine Generalized body weakness Sneezing Runny nose Itchy eyes Runny eyes Itchy skinMedDRA releases: 2024-11 · check-in free text available
-
2022-02-12
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-12 | Unsuccessful |
Free text
Release 3 — day 14, dose 1
Symptoms: Headache for 2 days
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Runny nose, ear pressure popping sensation
Release 11 — 12 months, dose 2
Symptoms: Tested Covid positive Cough Fatigue Optical migraine Generalized body weakness Sneezing Runny nose Itchy eyes Runny eyes Itchy skin
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Eye pruritus | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lacrimation increased | · | · | ✓ |
| SD | Ophthalmic migraine | · | · | ✓ |
| SD | Pruritus | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Ear discomfort | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release